Stock overview
Aktis Oncology Inc.
Explore the company, reported ownership, price history, and available source evidence.
AKTIS ONCOLOGY INC (AKTS) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $16.10
- · AKTS
- Tracked holders
- 4 funds
- Latest available 13F per fund
AKTS · USD
Price
Close · Nov 18, 2026
- Range low
- $14.59
- Range high
- $17.45
- Observations
- 23
- Session date
- Nov 18, 2026
Oct 19, 2026–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Baker Bros. Advisors largest tracked holder Q3 2026 · filed Nov 16, 2026 · SEC filing | — | $19,398,954 | 0.09% |
| Polen Capital Management position history Q3 2026 · filed Nov 13, 2026 · SEC filing | +15% 26'Q3 | $1,417,319 | 0.02% |
| Renaissance Technologies position history Q3 2026 · filed Nov 12, 2026 · SEC filing | −68% 26'Q3 | $594,594 | 0% |
| Tudor Investment Corp position history Q3 2026 · filed Nov 16, 2026 · SEC filing | +17% 26'Q3 | $486,361 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market